DOE accelerates evaluation of new medical radioisotopes

April 13, 2022, 12:00PMNuclear News

The Department of Energy announced on April 11 that it will distribute $1 million to three awardees to evaluate newly developed radioisotopes for potential therapeutic use in preclinical and clinical trials. The funding is provided by the DOE Isotope Program, which produces isotopes for use in science, medicine, and industry that would otherwise be unavailable or in short supply.

To continue reading, log in or create a free account!

Related Articles

Taking a train to Texas

As part of its DUF6 conversion program, the DOE is shipping converted depleted uranium oxide to WCS for disposal.

April 11, 2024, 7:01AMRadwaste Solutions

Last year in late August, 120 storage cylinders of depleted uranium oxide (DUOx) safely arrived by rail in West Texas, having been shipped from the Department of Energy’s Portsmouth Site in...